USPTO serial 79445721
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Neil A. Salyards
Neil A. Salyards Procopio, Cory, Hargreaves & Savitch LLP525 B Street, Suite 2200San Diego, CA 92101United States| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and medical preparations for the treatment of psychiatric, central nervous system, gastrointestinal, hepatic, biliary, immunological, allergic, inflammatory, metabolic, autoimmune and neurological diseases and disorders; pharmaceutical preparations for the relief of pain being anesthesia; pharmaceutical, vegetal being medicinal herbal, medicinal herbal, and natural pharmaceutical preparations and substances for the treatment of anxiety and depression; vitamins; minerals as food supplements; food supplements; nutritional supplements; chemical preparations for pharmaceutical purposes, namely, for the treatment of central nervous system, gastrointestinal, hepatic, biliary, immunological, allergic, inflammatory, metabolic, autoimmune, neurological, psychiatric and pediatric diseases and disorders; diagnostic preparations for medical use; diagnostic reagents for medicinal use; veterinary preparations, namely, pain relief medication; medicated gels, creams and lubricants | ACTIVE | — |
| 035 | Retail and wholesale services, namely, retail and wholesale stores featuring pharmaceutical preparations, medicines, medical, surgical and dental apparatus and instruments, nutritional supplements, vitamins, mineral supplements; business management services, namely, administration of business engaged in the field of pharmaceutical preparations and medical products; providing office functions; import agency services in the field of pharmaceutical preparations and medical products; sales promotion services; business consulting services; business information services; public relations services; electronic commerce services, namely, providing information about products via telecommunication networks for advertising and sales purposes; purchase and rental of advertising space; direct mail advertising; business networking; arranging of business introductions being special events; advertising, marketing and promotional services relating to pharmaceuticals and medical products; marketing and promotion of pharmaceutical preparations and medical products; market research services relating to pharmaceuticals and medical products; conducting business surveys and the collection of data relating to pharmaceuticals, medical products and medical activities for business purposes; commercial information and consumer product advice relating to pharmaceuticals, medical products and medical information; organization of trade and commercial conferences and conventions relating to pharmaceuticals and medical products; distribution of samples; price comparison services and coupon procurement services for others in the field of pharmaceuticals and medical products | ACTIVE | — |
| 041 | Organization of business conferences and conventions relating to pharmaceuticals and medical products; education services, namely, training educators in the field of pharmaceutical preparations and medical products | ACTIVE | — |
| 042 | Research services in the field of pharmaceuticals and medical products; scientific research and technological consulting services in the field of product development in the field of pharmaceuticals; scientific research and technological consulting services in the field of design and product development in the field of pharmaceuticals; industrial analysis being consulting services in the field of design and product development of pharmaceuticals and medical products; industrial research being consulting and research services in the field of design and product development of pharmaceuticals and medical products; industrial design and development services being consulting, analysis and material testing services in the field of pharmaceuticals and medical products; design and development of artificial intelligence and machine learning software for use in the field of pharmaceuticals and medical products; design and development of products in the field of pharmaceuticals; development and design services relating to pharmaceutical preparations and medical products; molecule discovery services for use in the development of pharmaceuticals being drug discovery services. | ACTIVE | — |
| 044 | Medical services; veterinary services; hygienic and beauty care for human beings and animals | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 18, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 18, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 18, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 6, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 23, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 23, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 5, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 4, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 2, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 13, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 13, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 12, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |